Pilot Study of Safety and Efficacy of Spheramine

Clinical trial NCT00761436 · TERMINATED

Trial details

NCT number: NCT00761436
Sponsor: Bayer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson''s Disease

Start date: 2000-02-29
Primary completion: 2012-05-14
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.